Aneurysmal bone cysts: denosumab extends its reach

被引：5
作者：
Purdue, Edward [1 ]
机构：
[1] Hosp Special Surg, New York, NY 10021 USA
来源：
TRANSLATIONAL RESEARCH | 2014年 / 164卷 / 02期
关键词：
GIANT-CELL TUMOR; OSTEOCLAST DIFFERENTIATION; LIGAND;
D O I：
10.1016/j.trsl.2014.04.013
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：135 / 138
页数：4
相关论文
共 16 条
  • [1] Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
    Branstetter, Daniel G.
    Nelson, Scott D.
    Manivel, J. Carlos
    Blay, Jean-Yves
    Chawla, Sant
    Thomas, David M.
    Jun, Susie
    Jacobs, Ira
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4415 - 4424
  • [2] Giant cell tumor of bone: A basic science perspective
    Cowan, Robert W.
    Singh, Gurmit
    [J]. BONE, 2013, 52 (01) : 238 - 246
  • [3] GOLDRING SR, 1986, CLIN ORTHOP RELAT R, P59
  • [4] Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
    Lacey, DL
    Timms, E
    Tan, HL
    Kelley, MJ
    Dunstan, CR
    Burgess, T
    Elliott, R
    Colombero, A
    Elliott, G
    Scully, S
    Hsu, H
    Sullivan, J
    Hawkins, N
    Davy, E
    Capparelli, C
    Eli, A
    Qian, YX
    Kaufman, S
    Sarosi, I
    Shalhoub, V
    Senaldi, G
    Guo, J
    Delaney, J
    Boyle, WJ
    [J]. CELL, 1998, 93 (02) : 165 - 176
  • [5] Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts
    Lange, Tobias
    Stehling, Christoph
    Froehlich, Birgit
    Klingenhoefer, Mark
    Kunkel, Philip
    Schneppenheim, Reinhard
    Escherich, Gabriele
    Gosheger, Georg
    Hardes, Jendrik
    Juergens, Heribert
    Schulte, Tobias L.
    [J]. EUROPEAN SPINE JOURNAL, 2013, 22 (06) : 1417 - 1422
  • [6] Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor κB
    Morgan, T
    Atkins, GJ
    Trivett, MK
    Johnson, SA
    Kansara, M
    Schlicht, SL
    Slavin, JL
    Simmons, P
    Dickinson, I
    Powell, G
    Choong, PFM
    Holloway, AJ
    Thomas, DM
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (01) : 117 - 128
  • [7] Suppression of bone formation by osteoclastic expression of semaphorin 4D
    Negishi-Koga, Takako
    Shinohara, Masahiro
    Komatsu, Noriko
    Bito, Haruhiko
    Kodama, Tatsuhiko
    Friedel, Roland H.
    Takayanagi, Hiroshi
    [J]. NATURE MEDICINE, 2011, 17 (11) : 1473 - U181
  • [8] Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy
    Pauli, Chantal
    Fuchs, Bruno
    Pfirrmann, Christian
    Bridge, Julia A.
    Hofer, Silvia
    Bode, Beata
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [9] Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
    Pederson, Larry
    Ruan, Ming
    Westendorf, Jennifer J.
    Khosla, Sundeep
    Oursler, Merry Jo
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (52) : 20764 - 20769
  • [10] Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response
    Pelle, Dominic W.
    Ringler, Jonathan W.
    Peacock, Jacqueline D.
    Kampfschulte, Kevin
    Scholten, Donald J., II
    Davis, Mary M.
    Mitchell, Deanna S.
    Steensma, Matthew R.
    [J]. TRANSLATIONAL RESEARCH, 2014, 164 (02) : 139 - 148
12